Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableEnrolling By InvitationNCT07038213
What this trial is testing

Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
Astana Medical University 100
Not applicableUnknownNCT01215994
What this trial is testing

Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes MellitusDiabetic Nephropathy
AHEPA University Hospital 600
Not applicableUnknownNCT03178253
What this trial is testing

Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy

Who this might be right for
Hypothyroidism in Diabetes
Assiut University 100
Early research (Phase 1)Study completedNCT04880291
What this trial is testing

First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes

Who this might be right for
Kidney DiseasesDiabetic NephropathiesDiabetes Complications+2 more
Goldfinch Bio, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT07396155
What this trial is testing

Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

Who this might be right for
Diabetic Nephropathy Type 2
PT. Prodia Stem Cell Indonesia 10
Not applicableLooking for participantsNCT07485075
What this trial is testing

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Who this might be right for
Diabetes Type 2Kidney Disease
Steno Diabetes Center Copenhagen 104
Not applicableStudy completedNCT05691985
What this trial is testing

Fib to Alb Ratio in Type 2 Dkd

Who this might be right for
CKDType 2 Diabetes
Assiut University 50
Early research (Phase 1)Ended earlyNCT01488877
What this trial is testing

Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Nephropathy
Pfizer 6
Early research (Phase 1)Study completedNCT04990427
What this trial is testing

CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Chronic Kidney Diseases
Lisata Therapeutics, Inc. 6
Not applicableLooking for participantsNCT07444203
What this trial is testing

Transformative Research in Diabetic Nephropathy 2.0

Who this might be right for
Diabetic NephropathiesKidney DiseasesRenal Insufficiency, Chronic+1 more
University of Pennsylvania 200
Not applicableStudy completedNCT07498894
What this trial is testing

Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status

Who this might be right for
Diabetic Nephropathy Type 2Type 2 DiabetesPeriodontitis+2 more
Pamukkale University 126
Post-approval studies (Phase 4)Enrolling By InvitationNCT06954090
What this trial is testing

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Who this might be right for
Type 2 DMType 2 DM /Diabetic NephropathyAlbuminuria
Steno Diabetes Center Copenhagen 50
Not applicableLooking for participantsNCT04931537
What this trial is testing

Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.

Who this might be right for
Diabetic Nephropathy Type 2Biomarker
Second Affiliated Hospital, Zhejiang University, School of Medicine 1,000
Post-approval studies (Phase 4)UnknownNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Not applicableStudy completedNCT05631119
What this trial is testing

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney Diseases+1 more
Sanguine Biosciences 40
Not applicableUnknownNCT04119167
What this trial is testing

Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians

Who this might be right for
Diabetes Mellitus, Type 2Diabetic PolyneuropathyDiabetic Nephropathies
Chang Gung Memorial Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00734253
What this trial is testing

Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
NephroGenex, Inc. 317
Post-approval studies (Phase 4)Study completedNCT00272831
What this trial is testing

The Use of Cilostazol in Patients With Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Complications
Chinese University of Hong Kong 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920
What this trial is testing

Atrasentan in Patients With Proteinuric Glomerular Diseases

Who this might be right for
IgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more
Novartis Pharmaceuticals 103
Next Page